תאריך רישום: June 6, 1999

מסלול הגשה: מולקולה חדשה

יצרן: BAXTER HEALTHCARE S.A., IRELAND

בעל רישום: BAXTER HEALTHCARE DISTRIBUTION LTD., ISRAEL

B05AA05 :ATC Code

4.1 Therapeutic Indications Extraneal is recommended as a once daily replacement for a single glucose 4.4 Special Warnings and Precautions for Use exchange as part of a continuous ambulatory peritoneal dialysis (CAPD) or • Patients with diabetes mellitus often need additional insulin in order to automated peritoneal dialysis (APD) regimen for the treatment of chronic renal maintain glycaemic control during Peritoneal Dialysis (PD). Transfer from failure, particularly for patients who have lost ultrafiltration on glucose solutions, glucose based PD solution to Extraneal may necessitate an adjustment of the because it can extend time on CAPD therapy in such patients. usual insulin dosage. Insulin can be administered intraperitoneally.

תאריך רישום: May 2, 2007

מסלול הגשה: מולקולה חדשה

יצרן: BAUSCH & LOMB INCORPORATED, USA

בעל רישום: TEVA ISRAEL LTD

S01BA14 :ATC Code

תאריך רישום: June 28, 2018

מסלול הגשה: מולקולה חדשה

יצרן: ALCON COUVREUR N.V., BELGIUM

בעל רישום: NOVARTIS ISRAEL LTD

N02CX07 :ATC Code

4.1 Therapeutic indications Aimovig is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month when initiating treatment with Aimovig.

תאריך רישום: October 27, 2016

מסלול הגשה: מולקולה חדשה

יצרן: ASPEN BAD OLDESLOE GMBH, GERMANY

בעל רישום: PADAGIS ISRAEL AGENCIES LTD, ISRAEL

G03CA04 :ATC Code

4.1 Therapeutic indications For the treatment of vulvo-vaginal complaints related to estrogen deficiency.

תאריך רישום: May 12, 1999

מסלול הגשה: מולקולה חדשה

יצרן: TAKEDA GMBH, GERMANY

בעל רישום: TAKEDA ISRAEL LTD

A02BC02 :ATC Code

4.1 Therapeutic indications Controloc 20 mg: For the treatment of reflux oesophagitis and associated symptoms (e.g. heartburn, acid regurgitation, pain on swallowing). For long-term management and prevention of relapse in reflux oesophagitis. Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAIDs treatment (see section 4.4). Controloc 40 mg: Short term treatment of acute duodenal ulcer. Acute gastric ulcer. Moderate and severe reflux oesophagitis. Eradication of the Helicobacter pylori in combination with clarithromycin and amoxycillin or clarithromycin and metronidazole/tinidazole or amoxycillin and metronidazole/tinidazole in cases of duodenal ulcer and gastric ulcer with the objective of reducing the recurrence of duodenal and gastric ulcers caused by this microorganism. Zollinger-Ellison-Syndrome.

תאריך רישום: March 28, 1993

מסלול הגשה: מולקולה חדשה

יצרן: CENEXI , FRANCE

בעל רישום: PADAGIS ISRAEL AGENCIES LTD, ISRAEL

N01BB01 :ATC Code

4.1 Therapeutic indications Spinal anaesthesia for surgery.